Moving on up — from stage IV into stage III
نویسندگان
چکیده
منابع مشابه
Transvaginal Sacrospinous Ligament Fixation for Pelvic Organ Prolapse Stage III and Stage IV Uterovaginal and Vault Prolapse
The result of transvaginal sacrospinous ligament fixation technique, as part of the vaginal repair procedure for massive uterovaginal (Pelvic Organ Prolapse stage III and stage IV and vault prolapse) is evaluated. A total of 32 women were included in the present case series. Marked uterovaginal prolapse was present in 28 women and four had vault prolapse following hysterectomy. Patients with va...
متن کاملبررسی امکان تبدیل سطح استاندارد آلایندگی موتور perkins mt4244 از سطح stage ii به stage iii
چکیده ندارد.
15 صفحه اولA Stage Model of Behavioral Therapies Research: Getting Started and Moving on From Stage I
WHY DO WE NEED A STAGE MODEL? Research on efficacy and active components of behavioral treatments was revolutionized 20 years ago by the articulation of the technology model of research as exemplified by the National Institute of Mental Health Treatment of Depression Collaborative Research Program (Carroll & Rounsaville, 1990;Waskow, 1984). Akin to specifying the formulation and dosage of medic...
متن کاملtransvaginal sacrospinous ligament fixation for pelvic organ prolapse stage iii and stage iv uterovaginal and vault prolapse
the result of transvaginal sacrospinous ligament fixation technique, as part of the vaginal repair procedure for massive uterovaginal (pelvic organ prolapse stage iii and stage iv and vault prolapse) is evaluated. a total of 32 women were included in the present case series. marked uterovaginal prolapse was present in 28 women and four had vault prolapse following hysterectomy. patients with va...
متن کاملAflibercept (VEGF Trap) in inoperable stage III or stage iv melanoma of cutaneous or uveal origin.
PURPOSE Aflibercept is a soluble decoy VEGF receptor and angiogenesis inhibitor with potent preclinical antitumor activity in melanoma. We conducted a multicenter phase II study in patients with inoperable stage III or IV melanoma and no prior chemotherapy. EXPERIMENTAL DESIGN A two-stage design was adopted to evaluate 4-month progression-free survival rate (PFSR) and response rate. Afliberce...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Nature Reviews Clinical Oncology
سال: 2017
ISSN: 1759-4774,1759-4782
DOI: 10.1038/nrclinonc.2017.159